Physician profile
Hector Pallavicini
NPI 1992764831
$787.55
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $36.59 · 2021: $158 · 2022: $110 · 2024: $48.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $48.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $48.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $209.90 | 2021-2024 | |
| Abbott Laboratories | $148.11 | 2019 | |
| Amarin Pharma, INC. | $120.32 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $107.48 | 2021 | |
| Covidien LP | $104.40 | 2019-2020 | |
| Sanofi Pasteur INC. | $82.11 | 2019 | |
| Olympus America INC. | $15.23 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hector Pallavicini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.